Synergy Pharmaceuticals, Inc. (SGYP) - NASDAQ
From other sites
Company Description
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its lead product candidate includes plecanatide a phase 3 guanylate cyclase C, or GC-C, receptor agonist, designed to treat GI disorders,... More
Sector: Healthcare
Industry: Biotechnology
Country: United States